National Drug Code (NDC) Database
MENDAS PHARMA PRIVATE LIMITED
-
NDC:
87097-001
-
Nonproprietary Name:
GUAIFENESIN
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
25 kg/25kg
-
Substance:
GUAIFENESIN
-
Start Marketing Date:
2025-09-10
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Mentha & Allied Products Private Limited
-
NDC:
70440-001
-
Nonproprietary Name:
MENTHOL
-
Dosage Form:
CRYSTAL
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
MENTHOL
-
Start Marketing Date:
2016-01-27
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Merck Life Science Technologies (Nantong) Co., Ltd
-
NDC:
84105-220
-
Nonproprietary Name:
Zinc Chloride
-
Dosage Form:
CRYSTAL
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
ZINC CHLORIDE
-
Start Marketing Date:
2022-06-30
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Merck Life Science Technologies (Nantong) Co., Ltd.
-
NDC:
84105-204
-
Nonproprietary Name:
Sodium acetate trihydrate
-
Dosage Form:
CRYSTAL
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
SODIUM ACETATE
-
Start Marketing Date:
2024-02-07
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Merck Sharp & Dohme Corp.
-
NDC:
69806-0094
-
Nonproprietary Name:
CILASTATIN SODIUM
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
CILASTATIN SODIUM
-
Start Marketing Date:
2015-08-24
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Merck Sharp & Dohme LLC
-
NDC:
0006-0138
-
Nonproprietary Name:
IMIPENEM ANHYDROUS, cilastatin, and RELEBACTAM ANHYDROUS
-
Dosage Form:
INJECTION, POWDER, FOR SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
500; 500; 250 mg/100mL; mg/100mL; mg/100mL
-
Substance:
CILASTATIN; IMIPENEM ANHYDROUS; RELEBACTAM ANHYDROUS
-
Start Marketing Date:
2020-01-06
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Merck Sharp & Dohme LLC.
-
NDC:
0006-0004
-
Nonproprietary Name:
suvorexant
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
20 mg/1
-
Substance:
SUVOREXANT
-
Start Marketing Date:
2014-08-15
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
CIV
-
Certified Through:
2026-12-31
-
NDC:
54784-027
-
Nonproprietary Name:
Bisoprolol Hemifumarate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
15 kg/15kg
-
Substance:
BISOPROLOL FUMARATE
-
Start Marketing Date:
2015-08-12
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
14639-9828
-
Nonproprietary Name:
di-Potassium hydrogen phosphate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
12 kg/12kg
-
Substance:
POTASSIUM PHOSPHATE, DIBASIC
-
Start Marketing Date:
2010-12-17
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
70153-003
-
Nonproprietary Name:
Metformin HCl plus 0.5 percent Mg Stearate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
85 kg/85kg
-
Substance:
METFORMIN HYDROCHLORIDE
-
Start Marketing Date:
2015-11-25
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.